Thrombin generation induced by tissue factor plus ADP in human platelet rich plasma: A potential new measurement to assess the effect of the concomitant use of an oral factor Xa inhibitor edoxaban and P2Y12 receptor antagonists-Reference-Cited by-同舟云学术

Thrombin generation induced by tissue factor plus ADP in human platelet rich plasma: A potential new measurement to assess the effect of the concomitant use of an oral factor Xa inhibitor edoxaban and P2Y12 receptor antagonists

Published:2015-05 Issue:5 Volume:135 Page:958-962
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Honda Yuko,Morishima Yoshiyuki

Publisher

Elsevier BV

Subject

Hematology

Reference19 articles.

1. Anticoagulation in atrial fibrillation;Steinberg;BMJ,2014

2. Incidence and severity of coronary artery disease in patients with atrial fibrillation undergoing first-time coronary angiography;Kralev;PLoS One,2011

3. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)

4. RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N Engl J Med,2009

5. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation;Patel;N Engl J Med,2011

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a super-hydrophilic anaerobic tube for the optimization of platelet-rich fibrin;Platelets;2024-02-22

2. Antithrombotic and prohemorrhagic actions of different concentrations of apixaban in patients exposed to single and dual antiplatelet regimens;Scientific Reports;2023-12-27

3. DOAC–associated bleeding, hemostatic strategies, and thrombin generation assays - a review of the literature;Journal of Thrombosis and Haemostasis;2023-03

4. Preanalytical variables and their potential impact on biomarkers and precision medicine initiative;Biomarkers, Diagnostics and Precision Medicine in the Drug Industry;2019

5. Oncostatin M was associated with thrombosis in patients with atrial fibrillation;Medicine;2017-05